Amgen To Pay $780M To Settle Drug Sales Suits
By Keith Goldberg · October 24, 2011, 10:50 PM EDT
Amgen Inc. said Monday it would pay $780 million to settle allegations over its sales and marketing practices stemming from civil and criminal investigations — including Medicaid claims and a whistleblower...
To view the full article, register now.